Condition
Subcutaneous Injection
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04434300Phase 1Completed
Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)
NCT07151638Not ApplicableCompleted
First-in-Human Safety Study for Fractomer™ Biomatrix
NCT06858514Not ApplicableCompleted
The Effect of Virtual Reality and Escape Rooms in Subcutaneous Injection Teaching
NCT05833646Not ApplicableCompletedPrimary
Comparison of the Effects of ShotBlocker, Virtual Reality Glasses and Cold Application in Subcutaneous Heparin Injection
NCT03583749Unknown
Pharmacokinetics and Safety of Antimicrobial Agents Administered by Subcutaneous Route in Patients AGEd Over 65 Years
Showing all 5 trials